Dr. Jordi Bové PhD
Neurodegenerative Diseases Group
Vall d’Hebron Research Institute (VHIR)
Barcelona | Spain

Jordi Bové received his Pharmacy degree from the University of Barcelona in 1998. In 2003, he got his PhD in Pharmacy (Neurobiology) with cum laude distinction from the same university at the Experimental Neurology Laboratory, Neurological Service of Hospital Clínic de Barcelona-IDIBAPS (Dr. C. Marin/Prof. E. Tolosa). His doctoral thesis shed light on the mechanism of levodopa-induced motor fluctuations in Parkinson’s disease. He later joined the laboratory of Dr. Serge Przedborski at Columbia University (New York, USA) as a post-doctoral researcher (2003-2005), working on animal modeling and the role of alpha-synuclein in Parkinson’s disease. In 2006 he co-founded the Neurodegenerative Diseases Research Group at Vall d’Hebron Research Institute (VHIR) in the Vall d’Hebron Hospital Campus (Barcelona) with its leader Dr. Miquel Vila. In 2011, he obtained a position as a Miguel Servet Investigator (Instituto de Salud Carlos III, Spain) as a Researcher in the National System of Health, and since then he is one of the principal investigators of the group. The research that he is leading is aimed to elucidate the mechanism of neuron cell death and to determine new therapeutic targets to develop neuroprotective strategies for Parkinson’s disease and other neurodegenerative diseases. He is also interested in establishing presymptomatic biomarkers of Parkinson´s disease. He is currently focused on the role of the adaptive immune system in Parkinson’s disease.